Intracranial Pressure Monitoring Market

Market Overview:

The global intracranial pressure monitoring market size reached US$ 1.7 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 2.5 Billion by 2028, exhibiting a growth rate (CAGR) of 6.9% during 2023-2028.

Intracranial pressure (ICP) monitoring is utilized in neurosurgery and neurology for measuring the pressure inside the skull. It can be performed using either invasive or non-invasive techniques. Amongst these, invasive techniques, such as ventriculostomy and micro transducers, involve drilling a hole in the skull using a burr hole or a twist drill technique for inserting the device. The device is connected to transducers for sending measurements and projecting cerebrospinal fluid (CSF) waveform. On the other hand, non-invasive techniques are generally utilized for avoiding complications of hemorrhages and infections associated with the former technique. They include transcranial Doppler, tympanic membrane displacement, optic nerve sheath diameter, magnetic resonance imaging (MRI) and fundoscopy. Nowadays, health professionals prefer using ICP monitors, clinical examination, and brain imaging to provide better results.

Owing to the increasing cases of coronavirus disease (COVID-19), the need for providing optimum care to patients under critical conditions is escalating around the world. This, in turn, is strengthening the ICP monitor market growth, as these devices are used for monitoring patients under intensive care. Apart from this, the rising number of individuals suffering from traumatic brain injury (TBI), represents another growth-inducing factor impelling market growth. Additionally, the increasing prevalence of autoimmune, cardiovascular and sleep disorders has catalyzed the demand for ICT monitors to provide early and effective treatment. Furthermore, governments of several countries are spending on improving the healthcare infrastructure and critical care centers, which is expected to boost the sales of these monitors. Additionally, manufacturers are also focusing on the introduction of an ICP monitoring device for home use. Such innovations are expected to create a positive outlook for the market growth in the coming years.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global intracranial pressure monitoring market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product type, technology, monitoring type, application and end-user.

Breakup by Product Type:

• Monitors
• Probes
• Catheters and Kits
• Other Accessories
   

Breakup by Technology:

• Invasive
  • External Ventricular Drainage (EVD)
  • Microtransducer ICP Monitoring
• Non-invasive
  • Transcranial Doppler Ultrasonography
  • Tympanic Membrane Displacement
  • Optic Nerve Sheath Diameter
  • MRI/CT
  • Others
     

Breakup by Monitoring Type:

• Intraventricular
• Intraparenchymal
• Epidural
• Others
   

Breakup by Application:

• Traumatic Brain Injury
• Intracerebral Hemorrhage
• Meningitis
• Others
   

Breakup by End-User:

• Hospitals
• Home Care
• Trauma Centers
• Others
   

Breakup by Region:

• North America
  • United States
  • Canada
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
• Latin America
  • Brazil
  • Mexico
  • Others
• Middle East and Africa
   

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being DePuy Synthes (Johnson & Johnson), HeadSense Medical Ltd., Integra Lifesciences Corporation, LINET Ltd., Medtronic plc, Natus Medical Incorporated, Raumedic AG (Rehau), Sophysa, Spiegelberg Gmbh (SHS), etc.

Report Coverage: